Comparison of Tofacitinib and Methotrexate in the Maintained Treatment of GPA

NCT04944524 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Granulomatosis With Polyangiitis

Interventions

DRUG: Tofacitinib
DRUG: Methotrexate

Sponsor

Shanghai Zhongshan Hospital